Gustavo Patricio Espinosa Lucero

12 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• PESTICIDE11 refused lines

  Pesticide chemical residue

  The product appeared to contain a pesticide chemical residue that makes it adulterated under section 402(a)(2)(B) of the FD&C Act, for example a residue above the U.S. tolerance or one with no U.S. tolerance for that food.

• LACKS N/C1 refused line

  Net quantity statement missing

  The packaged food appeared not to carry an accurate statement of the quantity of contents, such as net weight, measure, or count, on its label.

• NO ENGLISH1 refused line

  Required label information not in English

  Information that must appear on the label appeared not to be given in English, or not to be repeated in every language used on the label.

Questions about Gustavo Patricio Espinosa Lucero

Is Gustavo Patricio Espinosa Lucero on an FDA import alert?

Yes. As of October 26, 2026, Gustavo Patricio Espinosa Lucero is on the red list of FDA Import Alert 99-05, “Raw agricultural products: pesticides”, for fresh taro dasheens (malanga lila); FDA published the listing on January 22, 2020.

Has FDA refused shipments from Gustavo Patricio Espinosa Lucero?

Yes. FDA refused 11 shipment lines from Gustavo Patricio Espinosa Lucero between December 31, 2019 and June 1, 2020. The most recent, on June 1, 2020, was taro, dasheen (root & tuber vegetable), charged as PESTICIDE (pesticide chemical residue).

Why did FDA refuse Gustavo Patricio Espinosa Lucero's shipments?

The most frequent charges are PESTICIDE (pesticide chemical residue, 11 lines) and LACKS N/C (net quantity statement missing, 1 line).

What is Gustavo Patricio Espinosa Lucero's FEI number?

Gustavo Patricio Espinosa Lucero's FDA Establishment Identifier (FEI) is 3015429272.

Can shipments from Gustavo Patricio Espinosa Lucero still enter the U.S.?

Shipments of fresh taro dasheens (malanga lila) from Gustavo Patricio Espinosa Lucero can be detained without physical examination under Import Alert 99-05; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).